Refined vaccines and adjuvants are urgently needed to advance immunization against global infectious challenges such as HIV. hepatitis C. tuberculosis and malaria. Large-scale screening efforts are ongoing to identify adjuvants with improved efficacy profiles. https://www.ldartstudio.com/product-category/default/